Stereostructure-activity studies on agonists at the AMPA and kainate subtypes of ionotropic glutamate receptors

作者: Tommy N. Johansen , Jeremy R. Greenwood , Karla Frydenvang , Ulf Madsen , Povl Krogsgaard-Larsen

DOI: 10.1002/CHIR.10177

关键词:

摘要: (S)-Glutamic acid (Glu), the major excitatory neurotransmitter in central nervous system, operates through ionotropic as well metabotropic receptors and is considered to be involved certain neurological disorders degenerative brain diseases that are currently without any satisfactory therapeutic treatment. Until recently, development of selective Glu receptor agonists had mainly been based on lead compounds, which were frequently naturally occurring excitants structurally related Glu. These generally contain heterocyclic acidic moieties, has stimulated use bioisosteric replacement approaches for design subtype-selective agonists. Furthermore, most these leads conformationally restricted stereochemically well-defined analogs. Crystallization agonist binding domain GluR2 subunit (RS)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic (AMPA) subtype presence or absence an provided important information about ligand–receptor interaction mechanisms. The availability crystal structures formed basis rational ligands, especially AMPA kainate subtypes receptors. This mini-review will focus structure–activity relationships with special emphasis stereochemical three-dimensional aspects. Chirality 15:167–179, 2003. © 2003 Wiley-Liss, Inc.

参考文章(77)
Timothy A. Shepherd, James A. Aikins, David Bleakman, Buddy E. Cantrell, John P. Rearick, Richard L. Simon, Edward C. R. Smith, Gregory A. Stephenson, Dennis M. Zimmerman, Allan Mandelzys, Keith R. Jarvie, Ken Ho, Michelle Deverill, Rajender K. Kamboj, Design and synthesis of a novel series of 1,2-disubstituted cyclopentanes as small, potent potentiators of 2-amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)propanoic acid (AMPA) receptors. Journal of Medicinal Chemistry. ,vol. 45, pp. 2101- 2111 ,(2002) , 10.1021/JM0105474
Ronald A. Hill, Lane J. Wallace, Duane D. Miller, David M. Weinstein, Gamal Shams, Henry Tai, Richard T. Layer, David Willins, Norman J. Uretsky, Satyavijayan Narasimhan Danthi, Structure−Activity Studies for α-Amino-3-hydroxy-5-methyl-4-isoxazolepropanoic Acid Receptors: Acidic Hydroxyphenylalanines Journal of Medicinal Chemistry. ,vol. 40, pp. 3182- 3191 ,(1997) , 10.1021/JM950028Z
Nicola K Thomas, Lynda M Hawkins, Jacqueline C Miller, Helen M Troop, Peter J Roberts, David E Jane, Pharmacological differentiation of kainate receptors on neonatal rat spinal motoneurones and dorsal roots. Neuropharmacology. ,vol. 37, pp. 1223- 1237 ,(1998) , 10.1016/S0028-3908(98)00124-5
P. Krogsgaard-Larsen, T. Honoré, J. J. Hansen, D. R. Curtis, D. Lodge, New class of glutamate agonist structurally related to ibotenic acid Nature. ,vol. 284, pp. 64- 66 ,(1980) , 10.1038/284064A0
Tommy N Johansen, Yves L Janin, Birgitte Nielsen, Karla Frydenvang, Hans Bräuner-Osborne, Tine B Stensbøl, Stine B Vogensen, Ulf Madsen, Povl Krogsgaard-Larsen, None, 2-Amino-3-(3-hydroxy-1,2,5-thiadiazol-4-yl)propionic acid: resolution, absolute stereochemistry and enantiopharmacology at glutamate receptors. Bioorganic & Medicinal Chemistry. ,vol. 10, pp. 2259- 2266 ,(2002) , 10.1016/S0968-0896(02)00041-X
Hans Bräuner-Osborne, Jan Egebjerg, Elsebet Ø. Nielsen, Ulf Madsen, Povl Krogsgaard-Larsen, Ligands for glutamate receptors: design and therapeutic prospects. Journal of Medicinal Chemistry. ,vol. 43, pp. 2609- 2645 ,(2000) , 10.1021/JM000007R
Tine B Stensbøl, Frank A Sløk, Joseph Trometer, Stephen Hurt, Bjarke Ebert, Connie Kjøller, Jan Egebjerg, Ulf Madsen, Nils H Diemer, Povl Krogsgaard-Larsen, Characterization of a new AMPA receptor radioligand, [3H]2-amino-3-(3-carboxy-5-methyl-4-isoxazolyl)propionic acid. European Journal of Pharmacology. ,vol. 373, pp. 251- 262 ,(1999) , 10.1016/S0014-2999(99)00269-1
Christian Rosenmund, Yael Stern-Bach, Charles F Stevens, The Tetrameric Structure of a Glutamate Receptor Channel Science. ,vol. 280, pp. 1596- 1599 ,(1998) , 10.1126/SCIENCE.280.5369.1596